Condition

Inflammation (1)

Rheumatoid Arthritis (1)

Overall Status

Terminated (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

Novo Nordisk A/S (1)

Collaborator

Intervention

nnc0109-0012 (1)

placebo (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

Inflammation

Showing NaN - NaN of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Inflammation, Rheumatoid Arthritis Trial in Worldwide (NNC0109-0012, )

Terminated

Inflammation
Rheumatoid Arthritis

NNC0109-0012
placebo

Huntsville, Alabama
+163 more

Sep 3, 2018